- Home
- BBOT vs CNMD Comparison
BBOT vs CNMD Comparison
Compare BBOT & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBOT | CNMD |
|---|---|---|
| Founded | 2016 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | BBOT | CNMD |
|---|---|---|
| Price | $8.70 | $36.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | $24.00 | ★ $48.00 |
| AVG Volume (30 Days) | 184.8K | ★ 374.4K |
| Earning Date | 03-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $1,374,724,000.00 |
| Revenue This Year | N/A | $0.82 |
| Revenue Next Year | N/A | $5.48 |
| P/E Ratio | ★ N/A | $23.87 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $8.67 | $35.37 |
| 52 Week High | $14.87 | $61.25 |
Technical Indicators
Market Signals| Indicator | BBOT | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 32.20 |
| Support Level | N/A | $35.37 |
| Resistance Level | $12.36 | $46.08 |
| Average True Range (ATR) | 0.55 | 1.37 |
| MACD | -0.05 | -0.34 |
| Stochastic Oscillator | 3.28 | 15.44 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
About CNMD CONMED Corporation
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.